| Document and Entity Information | Oct. 17, 2022 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Oct. 17, 2022 |
| Entity Registrant Name | Athira Pharma, Inc. |
| Entity Central Index Key | 0001620463 |
| Entity Incorporation, State or Country Code | DE |
| Entity File Number | 001-39503 |
| Entity Tax Identification Number | 45-3368487 |
| Entity Address, Address Line One | 18706 North Creek Parkway |
| Entity Address, Address Line Two | Suite 104 |
| Entity Address, City or Town | Bothell |
| Entity Address, State or Province | WA |
| Entity Address, Postal Zip Code | 98011 |
| City Area Code | 425 |
| Local Phone Number | 620-8501 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, $0.0001 par value per share |
| Trading Symbol | ATHA |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | true |
| Entity Ex Transition Period | false |
